Sign in to continue:

Thursday, March 5th, 2026

MISTRAS Group Reports Record 2025 Q4 and Full Year Results: Revenue Growth, Margin Expansion, and Strong Adjusted EBITDA





Mistras Group Reports Record Adjusted EBITDA and Margin Expansion in FY2025, Sets Strategic Focus for 2026

Mistras Group Reports Record Adjusted EBITDA and Margin Expansion in FY2025, Sets Strategic Focus for 2026

Key Financial Highlights and Strategic Comments from Leadership

Mistras Group, Inc. (NYSE: MG), a leader in technology-enabled industrial asset integrity and testing solutions, has released its financial results for the fourth quarter and full year ended December 31, 2025. The results demonstrate notable improvements in revenue growth, profitability, and operational execution, marking a record year for the company and providing important forward-looking insights for investors.

Q4 2025 Key Financial Results

  • Revenue: \$181.5 million, up 5.1% year-over-year, with growth across all business segments.
  • Gross Profit: \$51.5 million, with a gross margin of 28.4% (an expansion of 190 basis points).
  • Net Income: \$3.9 million, or \$0.12 per diluted share.
  • Record Adjusted EBITDA: \$24.8 million, up 18.2% year-over-year, with an Adjusted EBITDA margin of 13.7% (up 160 basis points).

Full Year 2025 Key Financial Results

  • Revenue: \$724.0 million (slight increase, after adjusting for \$7.0 million in voluntary laboratory consolidations).
  • Gross Profit: \$204.5 million, gross margin of 28.2% (up 190 basis points).
  • Net Income: \$16.8 million, or \$0.53 per diluted share.
  • Record Adjusted EBITDA: \$91.1 million, up 10.5% year-over-year, with an Adjusted EBITDA margin of 12.6% (up 130 basis points).
  • Net Income Excluding Special Items (Non-GAAP): \$28.1 million, or \$0.88 per diluted share (compared to \$22.7 million and \$0.72 in FY2024).

Additional Financial Details

  • Income from Operations: \$40.6 million for FY2025, up from \$39.8 million last year. On a non-GAAP basis (before special items), income from operations was \$55.0 million versus \$46.2 million in the prior year.
  • Reorganization and Other Costs: \$12.7 million for FY2025, including \$4.9 million in Q4, as part of ongoing cost reduction and overhead recalibration initiatives.
  • Cash Flow: Net cash provided by operating activities was \$33.0 million (down from \$50.1 million in FY2024), with free cash flow (non-GAAP) at \$3.8 million (down from \$27.1 million), largely due to higher accounts receivable and increased capital expenditures.
  • Debt: Gross debt was \$178.0 million as of December 31, 2025 (up from \$169.6 million). Net debt (non-GAAP) was \$150.0 million (versus \$151.3 million last year). The leverage ratio stands at approximately 2.5x, well below the maximum allowable ratio under the company’s credit agreement.

Segment and Industry Performance

  • North America: \$584.1 million revenue in FY2025, with \$154.5 million gross profit.
  • International: \$143.8 million revenue, \$43.1 million gross profit.
  • Products & Systems: \$14.0 million revenue, \$7.4 million gross profit.
  • Key Sectors: Oil & Gas (\$396.8M), Aerospace & Defense (\$93.8M), Industrials (\$80.7M), Power Generation (\$44.2M), Infrastructure/Research/Engineering (\$37.5M).
  • Revenue by Type: Field Services (\$525.8M), Laboratories (\$72.4M), Data Analytics & Solutions (\$67.8M), Other (\$108M).

Executive Leadership Comments

Natalia Shuman, President & CEO: “Our 2025 performance demonstrates meaningful progress in profitability, achieving record Adjusted EBITDA and our highest margin to date. The improvement is due to disciplined execution, margin expansion, and a focus on higher-return opportunities. We are well positioned for profitable growth in 2026, driven by growing demand and our strong track record.”

Manny Stamatakis, Executive Chairman: “The Board fully supports management’s ongoing investment strategy in digital inspection, specialized talent, and accreditation for high-complexity aerospace and defense work. We see 2026 as a pivotal year to accelerate our strategy and deepen our technical differentiation.”

Strategic and Operational Updates

  • Reclassification of Overhead and Personnel Expenses: The company reclassified \$5.5 million (Q4) and \$20.9 million (FY25) from SG&A to cost of revenue, with no impact on income from operations, net income, or Adjusted EBITDA.
  • 2026 Outlook: Mistras will provide formal guidance during its scheduled conference call. The company will focus on further investments in data integrity, digital inspection, and high-value markets.
  • Debt Reduction: Management reiterated that reducing debt remains a priority for free cash flow allocation.
  • Risks: The company highlighted continued risks related to customer concentration in oil and gas, geopolitical instability, climate change, ability to attract talent, and other operational and market uncertainties.

Potential Price-Sensitive Factors for Investors

  • Record Adjusted EBITDA and Margin Expansion: The achievement of record profitability metrics and ongoing margin improvement may positively influence investor sentiment and share valuation.
  • Operational Cost Initiatives: While reorganization costs were elevated, these are tied to ongoing efficiency and recalibration efforts that could enhance future profitability.
  • Lower Free Cash Flow: The significant decrease in free cash flow due to higher working capital and capex may be viewed negatively, but management attributes this to timing and strategic investments.
  • Debt Level and Leverage Ratio: While gross debt has increased, the net leverage remains well within covenants, and continued debt reduction could be a positive catalyst.
  • Strategic Investments for 2026: The company’s stated intent to deepen investments in digital and high-complexity solutions could position Mistras for accelerated growth in regulated and mission-critical sectors.
  • Segment and End-Market Diversification: Continued expansion in Aerospace & Defense, Infrastructure, and Industrial sectors reduces reliance on Oil & Gas and supports long-term growth prospects.

Conference Call Details

Mistras will hold a conference call on March 5, 2026, at 9:00 a.m. EST to discuss these results and provide further guidance for 2026. Investors can access the webcast and participate in Q&A via the Investor Relations section of the company’s website.

About Mistras Group

Mistras Group, Inc. is a global leader in industrial asset integrity and laboratory testing solutions, serving critical industries such as oil & gas, aerospace & defense, power & utilities, manufacturing, and infrastructure. Its portfolio ranges from advanced non-destructive testing to predictive analytics, helping clients reduce risk and optimize performance.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. The information is based on the company’s official filings and press releases, which include forward-looking statements subject to risks and uncertainties.




View Mistras Group, Inc. Historical chart here



Diamond Hill Investment Group Announces Merger Agreement with First Eagle Investment Management – Form 8-K Filing and Supplemental Proxy Statement Disclosures 89

Diamond Hill Investment Group Issues Supplemental Disclosures Amid Shareholder Litigation Diamond Hill Investment Group Issues Supplemental Disclosures Amid Shareholder Litigation Over Merger Key Developments in Ongoing Special Meeting and Merger with First Eagle Diamond...

FingerMotion Announces Annual Meeting Results, Board Elections, and Strategic Growth Plans in China Market 12

Highlights from the Annual Meeting Board of Directors Election: Six directors were elected to the Board: Martin J. Shen, Hsien Loong Wong, Yew Poh Leong, Eng Ho Ng, Tuck Seng Low, and Yang Yeat...

ImmunityBio, Inc. (IBRX) 2025 Annual Report: Financial Statements, Equity, Warrants, and Related Party Transactions Overview

ImmunityBio, Inc. 10-K Report: Key Financial and Shareholder Highlights ImmunityBio, Inc. 10-K Report: Detailed Analysis for Investors Key Financial Highlights Fiscal Year Focus: The report covers financials up to December 31, 2025, with comparative...

   Ad